
AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Michelle Hoiseth, Chief Data Officer for Parexel and Dr. GunjanRead More
The cost of developing a new drug roughly doubles everyRead More
In medicine, a Biomarker is a biological indicator, which canRead More
This blog is adapted from my book titled “Inside the Cockpit: Navigating the Complexity of Drug Development with AI and Blockchain”. Full copies are available here. In December 2014, a twenty-nine-year-old investor named Vivek Ramaswamy bought a patent from GlaxoSmithKline (GSK) for $5 million. The patent covered an Alzheimer’s drug candidate that had failed GSK’s …
You Can’t Find the Needle If You Don’t Know It Exists Read More »
Computer vision is one such AI technology that has seen exponential breakthrough over the last few years. Today, the technology is being realized in many forms and to solve various problems across different industries. Besides its very popular application in facial recognition and driverless cars, one of the attractive uses of computer vision is data …
Extracting Medical Data with Computer Vision Technology Read More »
Dr. Gunjan Bhardwaj with Shanna Landolt for an exclusive podcast on how AI and Big Data is transforming the future of healthcare. http://traffic.libsyn.com/force-cdn/highwinds/shannalandolt/Dr._Gunjan_Bhardwaj.mp4 Gunjan Bhardwaj is the Founder and CEO of the Innoplexus group. He was earlier with the Boston Consulting Group and before that the leader of the global business performance think-tank of Ernst …
How AI and Big Data is transforming the future of healthcare Read More »